A smaller proportion of women vs. men underwent lung transplantation, plus women spent a longer time on the wait list before ...

Quadratech Diagnostics introduces Factor-X Activator RVV-X globally: United Kingdom Tuesday, January 21, 2025, 16:00 Hrs [IST] Quadratech Diagnostics, a provider of high quality m ...

The "Home Care Testing Market Size, Share & Trends Analysis Report By Age, By Sample, By Test Type, By Distribution Channel, ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

The FDA has granted breakthrough therapy designation to Bluejay Therapeutics’ brelovitug for the treatment of chronic hepatitis delta, for which no approved therapies currently exist in the U.S., the ...

TC Biopharm (Holdings) plc intends to begin proof-of-concept preclinical studies for its lead therapeutic TCB-008, to treat H5N1, or bird flu. TCB-008 is an allogeneic, unmodified cell therapy ...

Breakthrough Therapy Designation is designed to expedite the development and review of therapies that may show significant ...

As more Asia biotechs turn to regenerative medicine to address disorders without a cure, Medipost Inc. is continuing global expansion with Cartistem, its allogeneic human umbilical cord blood-derived ...

The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, is forecasted to grow at a robust CAGR of ...

Below is a review of novel drug and biological products approved by the Food and Drug Administration (FDA) in 2024. The list includes several groundbreaking therapies that are expected to change the ...

There are currently no treatments available for celiac disease beyond a gluten-free diet. Several late-phase companies aim to ...